Market for Prescription Dermatological Drugs, 7th Edition Report Now Available on ReportsandReports

0

Dallas, TX: ReportsandReports announce it will carry Market for Prescription Dermatological Drugs, 7th Edition Market Research Report in its Store.

This Kalorama Information report details the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future. The global market for prescription dermatology drugs includes products in the following categories:

• Prescription Acne and Rosacea Drugs

• Prescription Antiaging and Photodamage Drugs

• Prescription Dermatitis and Seborrhea Drugs

• Prescription Fungal Infection Drugs

• Prescription Hair Loss and Hair Removal Drugs

• Prescription Hyperpigmentation/Melasma Drugs

• Prescription Psoriasis Drugs

• Prescription Skin Cancer Drugs

• Other Prescription Skin Disorder Drugs

 The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products. Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities. By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology. This transition will play a role in the future development of the dermatological industry over the forecast period. The global pharmaceutical sector has little choice but to continue expanding through mergers and acquisitions for some time to come. It’s a very dynamic time for the industry focusing on a worldwide market, and among the trends covered in this report is:

 • Patient Compliance

• Cosmetic Dermatologists

• Melanoma Survival Rates Falter

• Phosphatidylglycerol and Psoriasis

• New Itch Gene Found

• New Filler Options

• Consumer Confusion

• Genetic Link to Psoriasis

• Biologic Dermatology

• Rx-to-OTC Switches

• Cosmeceuticals

• Antioxidants

• Polypeptides

• Teledermatology

• Reimbursement Issues

• Accutane IPledge Program

• Laser Therapy

• Narrowband Ultraviolet B

• Photodynamic Therapy

• New Oral Medications and Research for Acne

• Synthetic Lipids for Skin Healing

• Importance of Drug Delivery

The information and analysis presented in this report are based on extensive interviews with senior management of top companies in the dermatology market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 42 industry executives and product managers to validate and obtain expert opinion on current and future trends in the dermatological market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.

• Allergan Inc.

• Barrier Therapeutics, Inc

• Bayer AG

• PharmaDerm Pharmaceuticals, Inc

• Bristol-Myers Squibb

• Collagenex (now Galderma) Pharmaceuticals

• Galderma S.A.

• Genentech, Inc.

• GlaxoSmithKline Plc

• Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)

• Medicis Pharmaceutical Corporation

• Merck & Company, Inc.

• Mylan Pharmaceuticals, Inc,

• Novartis Pharmaceuticals Corporation

• Nycomed Inc.

• Pfizer, Inc.

• Q-Med AB

• Roche Group (F. Hoffmann-La Roche Ltd.)

• Schering (now Merck)-Plough Corporation

• Sinclair Pharma Plc.

• SkinMedica

• Stiefel Laboratories, Inc.

• Valeant Pharmaceuticals, Inc.

All market data pertains to the global market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2009. Historical data are provided for each of the years 2007 to 2009, and forecast data are provided for each of the years 2009 through 2014. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2009 base year.

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

Introduction

Scope and Methodology

Size and Growth of the Market

Issues and Trends Affecting Market

Competitor Analysis

CHAPTER TWO: INTRODUCTION

Structure and Function of the Skin

Epidermis

Dermis

Subcutaneous Tissue

Epidermal Appendages

Functions of the Skin

Effects of Aging on the Skin

Dermatological Conditions and Treatment

Pharmacokinetics

Drug Absorption

Distribution

Bioavailability

Drug Delivery Methods

Demographics of Skin Disorders, Incidence, and Prevalence

CHAPTER THREE: ISSUES AND TRENDS

Patient Compliance

Cosmetic Dermatologists

Melanoma Survival Rates Falter

Phosphatidylglycerol and Psoriasis

New Itch Gene Found

New Filler Options

Consumer Confusion

Genetic Link to Psoriasis

Biologic Dermatology

Rx-to-OTC Switches

Cosmeceuticals

Antioxidants

Polypeptides

Teledermatology

Reimbursement Issues

Accutane IPledge Program

Laser Therapy

Narrowband Ultraviolet B

Photodynamic Therapy

New Oral Medications and Research for Acne

Synthetic Lipids for Skin Healing

Importance of Drug Delivery

CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS

Description of Disorders

Description of Products

Benzoyl Peroxide

Description of Products

Current Suppliers

Retinoids

Topical Formulations

Systemic Formulations

Current Suppliers

Antibiotics

Description of Products

Current Suppliers

Oral Contraceptives

Research and Development

Market Size and Growth

Global Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS

Overview

Description of Products

Keratolytics

Moisturizers

Retinoids

Sunscreens

Other Agents

Research and Development

Market Size and Growth

Global Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS

Overview

Description of Products

Topical Corticosteroids

Systemic Corticosteroids

Other Products

Research and Development

Market Size and Growth

Global Market by Type

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Future of the Market

Competitive Analysis

CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS

Overview

Description of Products

Systemic Formulations

Terbinafine

Itraconazole

Fluconazole

Griseofulvin

Ketoconazole

Current Suppliers

Topical Formulations

Polyenes

Azoles

Allylamines and Benzylamines

Other Topical Formulations

New Products

Current Suppliers

Research and Development

Market Size and Growth

Global Market by Type

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Future of the Market

Competitive Analysis

CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS

Overview

Description of Products

Antiandrogens

Androgen Inhibitors

Oral Contraceptives

Other Treatments

Research and Development

Market Size and Growth

Global Market by Type

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Future of the Market

Competitive Analysis

CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION / MELASMA DRUGS

Overview

Description of Products

Research and Development

Market Size and Growth

Global Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS

Overview

Description of Products

Topical Psoriasis Products

Anthralin

Coal Tar

Methoxsalen

Second-generation Retinoids

Tazarotene

Topical Vitamin D

Vitamin D Analogs

Vanos

Systemic Psoriasis Preparations

Betamethasone

Cortisone Acetate

Cyclosporine

Hydrocortisone

Methotrexate

Olopatadine Hydrochloride

Tacrolimus

Light Therapy

Biologics

Research and Development

Market Size and Growth

Global Market by Type

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Future of the Market

Competitive Analysis

CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS

Overview

Nonmelanoma Skin Cancers

Actinic Keratoses

Basal Cell Carcinoma

Squamous Cell Carcinoma

Cutaneous T-cell Lymphoma

Dysplastic Nevus Syndrome

Malignant Melanoma

Description of Products

5-Fluorouracil

Mechlorethamine/Nitrogen Mustard

Carmustine/BCNU (Topical)

Vinblastine (Intralesional) and Others

Research and Development

Market Size and Growth

Global Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS—ANTIVIRALS AND ANTIPARASITICS

Overview

Antivirals

Antiparasitics

Description of Products

Topical Antivirals

Antiviral Drugs

Immunoenhancing Drugs

Current Suppliers

Antiparasitic Agents

Current Suppliers

Other Skin Related Products

Research and Development

Market Size and Growth

Global Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

Overview

Total Market Size and Forecast

Market and Competitive Analysis

 

CHAPTER FOURTEEN: CORPORATE PROFILES

Allergan Inc

Allergan Inamed Corporation

Barrier Therapeutics, Inc

Bayer AG

PharmaDerm Pharmaceuticals, Inc

Bristol-Myers Squibb

Collagenex (now Galderma) Pharmaceuticals

Galderma S.A

Genentech, Inc

GlaxoSmithKline Plc

Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)

Medicis Pharmaceutical Corporation

Merck & Company, Inc

Mylan Pharmaceuticals, Inc,

Novartis Pharmaceuticals Corporation

Nycomed Inc

Pfizer, Inc

Q-Med AB

Roche Group (F. Hoffmann-La Roche Ltd.)

Schering (now Merck)-Plough Corporation

Sinclair Pharma Plc

SkinMedica

Stiefel Laboratories, Inc

Valeant Pharmaceuticals, Inc

APPENDIX: Company Directory

http://www.reportsandreports.com/market-reports/market-for-prescription-dermatological-drugs-7th-edition-the/

http://www.reportsandreports.com/market-reports/the-future-of-dermatology-therapeutics-analysis-and-market-forec/

http://www.reportsandreports.com/market-reports/dermatology-psoriasis-therapy-area-pipeline-report/

http://www.reportsandreports.com/market-reports/dermatology-skin-infections-or-dermatosis-or-skin-itching-therapy/

press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://www.reportsandreports.com/

Customer comments

No comments were found for Market for Prescription Dermatological Drugs, 7th Edition Report Now Available on ReportsandReports. Be the first to comment!